Effect of gemfibrozil and rifampicin on the pharmacokinetics of selexipag and its active metabolite in healthy subjects.

MLA

Bruderer, Shirin, et al. “Effect of Gemfibrozil and Rifampicin on the Pharmacokinetics of Selexipag and Its Active Metabolite in Healthy Subjects.” British Journal of Clinical Pharmacology, vol. 83, no. 12, Dec. 2017, pp. 2778–88. EBSCOhost, https://doi.org/10.1111/bcp.13379.

APA

Bruderer, S., Petersen, S. M., Boehler, M., Remeňová, T., Halabi, A., & Dingemanse, J. (2017). Effect of gemfibrozil and rifampicin on the pharmacokinetics of selexipag and its active metabolite in healthy subjects. British Journal of Clinical Pharmacology, 83(12), 2778–2788. https://doi.org/10.1111/bcp.13379

Chicago

Bruderer, Shirin, Sylla, Marc Petersen, Margaux Boehler, Tatiana Remeňová, Atef Halabi, and Jasper Dingemanse. 2017. “Effect of Gemfibrozil and Rifampicin on the Pharmacokinetics of Selexipag and Its Active Metabolite in Healthy Subjects.” British Journal of Clinical Pharmacology 83 (12): 2778–88. doi:10.1111/bcp.13379.